Nabta Health Closes $2 Million Pre-Series A to Expand Hybrid Care
Founded in 2017 by Sophie Smith, the women’s health company plans to expand its AI-powered hybrid model, deepen employer and insurer partnerships, and bolster hospital-linked clinical infrastructure.
UAE-based women’s health company Nabta Health has secured $2 million in pre-Series A funding to expand its AI-powered hybrid model—combining digital, at-home, and in-clinic care—across the Middle East and Africa, bringing total funding to $4.5 million.
The company, founded in 2017 by Sophie Smith, will use the capital to build new diagnostic and at-home testing pathways, deepen ties with employers, insurers, and healthcare providers, and strengthen clinical infrastructure through hospital partnerships.
“This investment validates our vision - that women’s health in the region can be reimagined through an AI-powered, hybrid care model that meets women where they are, respects cultural context and delivers measurable outcomes. We are now looking to accelerate our growth so that more women and employers benefit from what we believe is the future of women-centred health: affordable, mobile-first, and engineered for sovereignty,” said Sophie Smith, Founder and CEO of Nabta Health. “For employers and insurers in the region, addressing the women’s health gap is not just a moral imperative; it is a business and productivity one. With this funding, we will drive scale, deepen impact and prepare for the next chapter of growth.”
This year, Nabta was named to TIME Magazine’s Top HealthTech Companies 2025 list, launched a Women’s Health Centre of Excellence in partnership with Clemenceau Medical Center Hospital Dubai, and expanded its corporate health solutions across the region. The company also plans to collaborate with leading hospitals to reinforce its clinical backbone as it rolls out new pathways across its hybrid model.
